Premium
This is an archive article published on November 3, 2011

Vaginal gel: ICMR says a long way to go

Karim is the Associate Scientific Director of the Centre for the AIDS Programme of Research in South Africa.

A group of 30 senior scientists from the Indian Council of Medical Research (ICMR) on Wednesday met Quarraisha Abdool Karim,the South African expert behind the first vaginal gel that was shown to successfully prevent HIV by over 50 per cent in a South African trial last year. The ICMR authorities said the area opened up strong prospects of joint research between the two countries under the South-South HIV collaboration programme.

Karim is the Associate Scientific Director of the Centre for the AIDS Programme of Research in South Africa. He had presented the first successful use of Tenofovir a drug for antiretroviral therapy (AIDS treatment) as microbicide gel to prevent HIV at the International AIDS Conference in Vienna in July 2010. His research was published in Science magazine.

Karims findings generated an excitement in the scientific world,resulting in WHO taking up the process of drawing guidelines for manufacturing,licensing and selling the product. Currently,the South African Government owns the licence for producing the gel.

We have been working with India on the South-South collaboration to fight HIV since last year,which is a collaborative effort with ICMR and the South African Government for joint research on HIV. I was invited for a talk to ICMR to discuss our findings after a series e-mail exchanges,and I got a very positive response from the academicians, Karim,who is in Delhi to attend the International Union Against Sexually Transmitted Infections (IUASTI) conference,told The Indian Express.

The ICMR,however,sounded a cautionary note. This was the first such interaction with South African experts on the subject. We have been engaged in interactions in the South-South HIV collaboration,and we will work towards planning our own research after this. It is too early to say whether it can be implemented in India yet, Dr K Satyanaryana,Head,Reproductive Health Research at ICMR,said.

 

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement